Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 37


Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).

Kotoula V, Krikelis D, Karavasilis V, Koletsa T, Eleftheraki AG, Televantou D, Christodoulou C, Dimoudis S, Korantzis I, Pectasides D, Syrigos KN, Kosmidis PA, Fountzilas G.

BMC Cancer. 2012 Aug 6;12:342. doi: 10.1186/1471-2407-12-342.


Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, Glentis S, Bournakis E, Bobos M, Pectasides D, Papakostas P, Pentheroudakis G, Gogas H, Skarlos P, Samantas E, Bafaloukos D, Kosmidis PA, Koutras A, Yannoukakos D, Konstantopoulou I, Fountzilas G.

Breast Cancer Res Treat. 2012 Jul;134(1):353-62. doi: 10.1007/s10549-012-2021-9. Epub 2012 Mar 21.


Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.

Kosmidis PA, Syrigos K, Kalofonos HP, Dimopoulos MA, Skarlos D, Pavlidis N, Boukovinas I, Bafaloukos D, Pectasides D, Bacoyiannis C, Fountzilas G.

Anticancer Res. 2012 Jan;32(1):175-81.


Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).

Kosmidis PA, Fountzilas G, Eleftheraki AG, Kalofonos HP, Pentheroudakis G, Skarlos D, Dimopoulos MA, Bafaloukos D, Pectasides D, Samantas E, Boukovinas J, Lambaki S, Katirtzoglou N, Bakogiannis C, Syrigos KN.

Ann Oncol. 2011 Apr;22(4):827-34. doi: 10.1093/annonc/mdq445. Epub 2010 Sep 29.


Treatment adherence of cancer patients to orally administered chemotherapy: insights from a Greek study using a self-reported questionnaire.

Saratsiotou I, Kordoni M, Bakogiannis C, Livadarou E, Skarlos D, Kosmidis PA, Razis E.

J Oncol Pharm Pract. 2011 Dec;17(4):304-11. doi: 10.1177/1078155210380292. Epub 2010 Aug 10.


Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Triantafillidis JK, Nasioulas G, Kosmidis PA.

Anticancer Res. 2009 Jul;29(7):2727-37. Review.


Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

Aravantinos G, Fountzilas G, Bamias A, Grimani I, Rizos S, Kalofonos HP, Skarlos DV, Economopoulos T, Kosmidis PA, Stathopoulos GP, Briasoulis E, Pectasides D, Samantas E, Timotheadou E, Papadimitriou C, Papanikolaou A, Onyenadum A, Papakostas P, Bafaloukos D, Dimopoulos MA; Hellenic Cooperative Oncology Group study.

Eur J Cancer. 2008 Oct;44(15):2169-77. doi: 10.1016/j.ejca.2008.06.035. Epub 2008 Aug 6.


Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.

Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA.

Ann Oncol. 2008 Jan;19(1):115-22. Epub 2007 Oct 15.


Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.

Kosmidis PA, Dimopoulos MA, Syrigos K, Nicolaides C, Aravantinos G, Boukovinas I, Pectasides D, Fountzilas G, Bafaloukos D, Bacoyiannis C, Kalofonos HP.

J Thorac Oncol. 2007 Feb;2(2):135-40.


Targeting anemia in patients with lung cancer.

Crawford J, Kosmidis PA, Hirsch FR, Langer CJ.

J Thorac Oncol. 2006 Sep;1(7):716-25. Review.


Metastatic pleural mesothelioma initially masquerading as chalazion.

Tsina EK, Papaioannou D, Matsouka FO, Kosmidis PA.

Br J Ophthalmol. 2006 Jul;90(7):921-2. Review. No abstract available.


Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering.

Cherny NI, Catane R, Kosmidis PA.

Ann Oncol. 2006 Jun;17(6):885-7. Epub 2006 Apr 20. No abstract available.


Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.

Barrett-Lee PJ, Ludwig H, Birgegård G, Bokemeyer C, Gascón P, Kosmidis PA, Krzakowski M, Nortier JW, Kongable G, Schneider M, Schrijvers D, Van Belle SJ; European Cancer Anaemia Survey Advisory Board and Participanting Centers.

Oncology. 2006;70(1):34-48. Epub 2006 Feb 21.


ESMO at 30: mission ongoing.

Kosmidis PA, Ludwig H, Mellstedt H.

Ann Oncol. 2005 Sep;16(9):1411-2. Epub 2005 Aug 1. No abstract available.


hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.

Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA, Nasioulas G.

Br J Cancer. 2005 Jan 31;92(2):396-404.


Treatment of carcinoid of the lung.

Kosmidis PA.

Curr Opin Oncol. 2004 Mar;16(2):146-9. Review.


Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.

Mihalatos M, Apessos A, Triantafillidis JK, Kosmidis PA, Fountzilas G, Agnantis NJ, Yannoukakos D, Nasioulas G.

Anticancer Res. 2003 May-Jun;23(3B):2691-5.


Ongoing and future trials of biologic therapies in lung cancer.

Bunn PA Jr, Shepherd FA, Sandler A, Le Chevalier T, Belani CP, Kosmidis PA, Scagliotti GV, Giaccone G.

Lung Cancer. 2003 Aug;41 Suppl 1:S175-86. Review.


Advanced NSCLC: new cytostatic agents.

Kosmidis PA, Manegold C.

Lung Cancer. 2003 Aug;41 Suppl 1:S123-32. Review.


Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.

Mihalatos M, Danielides I, Belogianni J, Harokopos E, Papadopoulou E, Kalimanis G, Tsiava M, Triantafillidis JK, Kosmidis PA, Fountzilas G, Basdanis G, Agnantis NJ, Yannoukakos D, Nasioulas G.

Cancer Genet Cytogenet. 2003 Feb;141(1):65-70.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk